{"url":"https://marfan-info.hatenablog.com/entry/2025/01/13/110116","categories":["\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc","Q & A","\u5c0f\u5150","\u5faa\u74b0\u5668","\u85ac"],"description":"Applying AHA's 2024 Scientific Statement: Navigating Diagnosis & Management of Pediatric Aortopathy 51:52-52:44 Q: Is atenolol the preferred treatment for children four and under? 4\u6b73\u4ee5\u4e0b\u306e\u5c0f\u5150\u306b\u3064\u3044\u3066\u306f\u3001\u30a2\u30c6\u30ce\u30ed\u30fc\u30eb\u306e\u307b\u3046\u304c\u597d\u307e\u3057\u3044\u3067\u3059\u304b\uff1f A: From the data, and I'll be curious to hear Dr. Lacro's thoughts, the data for atenolo\u2026","height":"190","published":"2025-01-13 11:01:16","version":"1.0","image_url":null,"provider_name":"Hatena Blog","type":"rich","author_url":"https://blog.hatena.ne.jp/marfan-info/","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmarfan-info.hatenablog.com%2Fentry%2F2025%2F01%2F13%2F110116\" title=\"\u5c0f\u5150\u306b\u304a\u3051\u308b\u30a2\u30c6\u30ce\u30ed\u30fc\u30eb\u3068\u30d7\u30ed\u30d7\u30e9\u30ce\u30ed\u30fc\u30eb\u306e\u6295\u4e0e\u306b\u3064\u3044\u3066 - \u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_name":"marfan-info","width":"100%","provider_url":"https://hatena.blog","blog_url":"https://marfan-info.hatenablog.com/","blog_title":"\u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates","title":"\u5c0f\u5150\u306b\u304a\u3051\u308b\u30a2\u30c6\u30ce\u30ed\u30fc\u30eb\u3068\u30d7\u30ed\u30d7\u30e9\u30ce\u30ed\u30fc\u30eb\u306e\u6295\u4e0e\u306b\u3064\u3044\u3066"}